Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab
Sponsor: Sanofi
Summary
This is a long-term study to collect data over 3 years in order to find out what is likely to happen in the future regarding participants 6 years of age and older who receive dupilumab for Atopic Dermatitis (AD) commonly known as Eczema, and to characterize real-world effectiveness, safety and use patterns of dupilumab in real world setting in France. Patients will be invited to participate if initiating treatment with dupilumab for AD according to French-specific prescribing information. The decision of initiation of the treatment is independent to the study's participation. The study will be conducted in approximately 50 centers in France to evaluate a representative sample of patients treated in France. At each participating site, all AD participants who receive an initial prescription for dupilumab will be invited to participate in this study, until the enrollment goal is achieved.
Official title: French Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis.
Key Details
Gender
All
Age Range
6 Years - Any
Study Type
OBSERVATIONAL
Enrollment
303
Start Date
2023-11-28
Completion Date
2028-05-10
Last Updated
2025-07-14
Healthy Volunteers
No
Conditions
Interventions
Dupilumab
Dupilumab cohort
Locations (42)
Investigational Site Number: 2500041
Amiens, France
Investigational Site Number: 2500037
Angers, France
Investigational Site Number: 2500021
Argenteuil, France
Investigational Site Number: 2500044
Armentières, France
Investigational Site Number: 2500018
Arras, France
Investigational Site Number: 2500011
Ars-Laquenexy, France
Investigational Site Number: 2500023
Avignon, France
Investigational Site Number: 2500001
Besançon, France
Investigational Site Number: 2500003
Bron, France
Investigational Site Number: 2500043
Caen, France
Investigational Site Number: 2500050
Chambéry, France
Investigational Site Number: 2500006
Clermont-Ferrand, France
Investigational Site Number: 2500005
Dijon, France
Investigational Site Number: 2500004
Epagny Metz Tessy, France
Investigational Site Number: 2500039
Fort-de-France, France
Investigational Site Number: 2500045
La Tronche, France
Investigational Site Number: 2500019
Le Havre, France
Investigational Site Number: 2500040
Le Mans, France
Investigational Site Number: 2500038
Les Sables-d'Olonne, France
Investigational Site Number: 2500048
Levallois-Perret, France
Investigational Site Number: 2500032
Lille, France
Investigational Site Number: 2500002
Limoges, France
Investigational Site Number: 2500036
Lorient, France
Investigational Site Number: 2500029
Marseille, France
Investigational Site Number: 2500028
Montpellier, France
Investigational Site Number: 2500024
Nantes, France
Investigational Site Number: 2500025
Nice, France
Investigational Site Number: 2500020
Nice, France
Investigational Site Number: 2500016
Pau, France
Investigational Site Number: 2500009
Périgueux, France
Investigational Site Number: 2500042
Poitiers, France
Investigational Site Number: 2500022
Pontoise, France
Investigational Site Number: 2500014
Romans-sur-Isère, France
Investigational Site Number: 2500008
Rouen, France
Investigational Site Number: 2500015
Saint-Germain-en-Laye, France
Investigational Site Number: 2500027
Saint-Mandé, France
Investigational Site Number: 2500026
Saint-Nazaire, France
Investigational Site Number: 2500035
Saint-Pierre, France
Investigational Site Number: 2500013
Saint-Pierre, France
Investigational Site Number: 2500012
Toulouse, France
Investigational Site Number: 2500010
Valence, France
Investigational Site Number: 2500031
Vandœuvre-lès-Nancy, France